09:00 — 09:30   Registration
  09:30 — 09:45   Chang Yi Wang王長怡, PhD, Chairperson, UBI group of companies
Hsu-Sung Kuo郭旭崧, MD, MPH, PhD, Director-General, Centers for Disease Control,
Ministry of Health and Welfare, R.O.C.
Welcome and Opening address
  09:45 — 10:15   Daniel R. Kuritzkes, MD
Progress towards HIV Cure
  10:15 — 10:45   Mathias D. Lichterfeld, MD, PhD
Diversity of the HIV-1 reservoir in CD4 T cell subsets
  10:45 — 11:15   Jonathan Li, MD
Predictors of HIV rebound after treatment interruption
  11:15 — 11:45   Flossie Wong-Staal黃以靜, PhD
Treatment with Potential for functional cure of HIV infection by monoclonal antibodies to CD4 mediating competitive HIV entry inhibition
  11:45 — 13:00   Lunch Break
  13:00 — 13:30   Wing-Wai Wong王永衛, MD
Viral suppression with UB-421 monotherapy in HIV infected adults
  13:30 — 14:00   Tae-Wook Chun, PhD
Therapeutic strategies aimed at achieving sustained virologic remission in HIV infection
  14:00 — 14:30   Hao Wu吳昊, MD
Long acting HIV fusion inhibitor albuvirtide in antiretroviral-experienced adults with HIV
  14:30 — 15:20   Yi-Ming Chen陳宜民, MD, ScD – Moderator
Panel Discussion
  15:20 — 15:30   Mei-June Liao廖美君, PhD, President, United BioPharma, Inc.
Closing Remarks